Jay Chhablani, MD

Jay Chhablani, MD, is vice chair of clinical trials at the University of Pittsburgh Medical Center Vision Institute in Pittsburgh, PA.

Articles by Jay Chhablani, MD

Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA

EURETINA 2025: Jay Chhablani, MD, provides an update on gene therapy for AMD and GA

ByJay Chhablani, MD,Hattie Hayes

October 10th 2025

Dr Chhablani said "having multiple approaches to the same problem" is key for reaching the maximum number of patients with age-related macular degeneration

Jay Chhablani, MD

Articles by Jay Chhablani, MD

EURETINA 2025: Jay Chhablani, MD, provides an update on gene therapy for AMD and GA

Latest Updated Articles

Trending on Ophthalmology Times Europe

SparingVision begins dosing patients with retinitis pigmentosa in NYRVANA clinical trial

Optogenetics for advanced retinal disease

Q&A: Sunir J. Garg, MD, shares endophthalmitis insights at AAO 2025